Clinical trial
Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine…
NCT00476983 · The HIV Netherlands Australia Thailand Research Collaboration, Other · Withdrawn
Key facts
| NCT number | NCT00476983 |
|---|---|
| Title | Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg |
| Official title | Pharmacokinetic and Efficacy of Saquinavir Mesylate Film Coated Tablet / Ritonavir 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg Once Daily in HIV Pretreated Patients |
| Lead sponsor | The HIV Netherlands Australia Thailand Research Collaboration, Other |
| Status | Withdrawn |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Saquinavir/Ritonavir BID or Lopinavir/Ritonavir BID |
| Intervention type | Drug |
| Interventions | saquinavir/ritonavir plus truvada |
| Enrollment | 0 |
| First posted | May 22, 2007 |
| Last update posted | Mar 30, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: